Zusammenfassung
Die Mehrzahl epidemiologischer Analysen über Verlauf und Komplikationen des Diabetes ist beeinträchtigt durch die fehlende Differenzierung in die nosologisch eigenständigen Typen I und II. Dieser Vorbehalt trifft auch auf so ergebnisreiche Untersuchungen wie die WHO Multinational Study of Vascular Disease in Diabetics [40] und viele der bekannten prospektiven Populationsstudien wie zum Beispiel von Framingham [10, 18] zu. Da epidemiologische Aussagen in besonderer Weise an die Dimension Zeit gebunden sind und die WHO-Klassifikation des Diabetes erst 1980 eingeführt wurde, ist dieses methodische Problem nicht kurzfristig zu lösen. Typendifferenzierte epidemiologische Analysen über Arteriosklerose und Diabetes können zur Zeit daher meist nur durch die nachträgliche Klassifizierung untersuchter Zielpopulationen vorgenommen werden, soweit die Studiendaten dies überhaupt zulassen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aro A (1984) Macroangiopathy in type II diabetes. Acta Endocrinol [Suppl 262]: 75–78
Barrett-Connor E, Orchard T (1985) Diabetes and heart disease. In: National Diabetes Data Group. Diabetes in America, NIH Publication No 85-1468. US Govt Printing Office, pp XVI/l–XVI/41
Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Deckert T, Poulsen JE, Larsen M (1978) Prognosis of diabetics with diabetes onset before age of thirtyone. Diabetologia 14: 363–377
Dorman JS, LaPorte RE, Kuller LH, Cruickshantes KJ, Orchard TJ, Wagner DK, Becker DJ, Cavender DE, Drash AL (1984) The Pittsburgh insulin-dependent diabetes mellitus ( IDDM) morbidity and mortality study. Diabetes 33: 271–276
Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE (1985) Diabetes, hyperglycaemia, hyperinsulinaemia and risk of coronary heart disease mortality. Data of the Paris Prospective Study, 10 years later. Rev Epidem Sante Publ 33: 352–357
Feingold KR, Siperstein MD (1986) Diabetic vascular disease. Adv Intern med 31: 309–340
Füller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 287: 867–870
Füller JH (1985) Causes of death in diabetes mellitus. Horm Metabol Res, Suppl Series No 15: 3–9
Garcia MJ, McNamara PM, Gordon T, Kanneil WB (1974) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23: 105–111
Hanefeld M, Schulze J, Fischer S, Julius U, Schmechel H, Haller H (1985) The diabetes Intervention study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results. Monogr Athe- roscler 13: 98–103
Herman JB, Medalie JH, Goldbourt U (1977) Differences in carciovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia 13: 229–234
Herman WH, Teutsch SM, Geis LS (1985) Closing the gap: the pro- blem of diabetes mellitus in the United States. Diabetes Care 8: 391–406
Jarrett RJ, Keen H, Chakrabarti R (1982) Diabetes, hyperglycaemia and arterial disease. In: Keen H, Jarrett RJ (eds) Complications of diabetes, 2nd edn. Edward Arnold, London, pp 179–203
Jarrett RJ (1984) The epidemiology of coronary heart disease and related factors in the context of diabetes mellitus and impaired glucose tolerance. In: Jarrett RJ (ed) Diabetes and heart disease. Elsevier, Amsterdam, pp 1–23
Jarrett RJ (1984) Type 2 (non-insulin-dependent) diabetes mellitus and coronar heart disease — chicken, egg or neither? Diabetologia 26:99–102
Janka HU (1985) Five-year incidence of major vascular complications in diabetes mellitus. Horm Metabol Res, Suppl Series No 15: 15–19
Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2: 120–126
Kannel WB (1981) Prospects for risk factor modification to reduce risk of reinfarction and premature death. J Cardiac Rehabil 1: 63–71
Kuller LH, Dorman JS, Wolf PA (1985) Cerebrovascular disease and diabetes. In: National Diabetes Data Group. Diabetes in America, NIH Publication No 85-1468. US Govt Printing Office, pp XVIII/l–XVIII/18
Marks HH, Krall LP (1971) Onset, course, prognosis and mortality in diabetes mellitus. In: Marble A, White P, Bradley RF, Krall LP (eds) Joslin’s Diabetes mellitus, llth edn. Lea and Febiger, Philadelphia, pp 209–254
Melton LJ, Ochi JW, Palumbo PJ, Chu CP (1984) Referral bias in diabetes re- search. Diabetes Care 7: 13–18
Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 6: 356–360
Ochi JW, Melton LJ, Palumbo PJ, Chu CP (1985) A population-based study of diabetes mortality. Diabetes Care 8: 224–229
Palumbo PJ, Elvebaak LR, Chu CP, Conolly DC, Kirkland LT (1976) Diabetes mellitus: incidence, prevalence, suvivorship and causes of death in Rochester Minnesota 1945–1970. Diabetes 25: 566–573
Palumbo PJ, Melton LJ (1985) Peripheral vascular disease and diabetes. In: National Diabetes Data Group. Diabetes in America, NIH Publication No 85-1468, US Govt Printing Office, pp XV/l–XV/21
Panzram G, Marx M, Frommhold E, Barthel R (1977) Untersuchungen über Sterbealter, erlebte Diabetesdauer und Todesursachen unter den Verstorbenen einer geschlossenen Diabetespopulation. Wien Klin Wochenschr 85: 147–150
Panzram G, Zabel-Langhenning R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587–591
Panzram G, Pissarek D, Michaelis D, Schliack V (1982) Ergebnisse einer multizentrischen Studie über den Langzeitdiabetes in der DDR-Population. Z Ges Inn Med 37: 617–621
Panzram G (1984) Epidemiologie data on excess mortality and life expectancy in insulin-dependent diabetes mellitus — critical review. Exp Clin Endocrinol 83: 93–100
Panzram G, Pissarek D (1985) Long-term diabetes — Associated factors in survivorship and mortality. Horm Metabol Res, Suppl Series No 15: 10–15
Panzram G (1987) Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (in press)
Pyörälä K, Laakso M (1983) Macrovascular disease in diabetes mellitus. In: Mann YI, Pyörälä K, Teuscher A (eds) Diabetes in epidemiological perspective. Churchill Livingstone, pp 183–247
Pyörälä K (1985) Diabetes and coronary heart disease. Acta Endocrinol 110 [Suppl 272]: 11–19
Pörälä K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis and epidemiologic view. Diabetes Metabolism Rev (in press)
Reunanen A (198rtalyti i3) Mon Type 2 diabetes. Ann Clin Res 15 [Suppl 37]26–28
Rytter LR, Troelsen S, Beck-Nielsen H (1985) Prevalence and mortality of acute myocardial infaretions in patients with diabetes. Diabetes Care 8: 230–234
Uusitupa M, Siitonen O, Pyörälä K, Aro A, Hersio K, Penttilä I, Voutilainen E (1985) The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed Type 2 (non-insulin-dependent) diabetes. Diabetologia 28: 653–659
WHO Multinational Study of Vascular Disease in Diabetics (1985) Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 28 [Suppl]: 615–640
WHO-Study Group on Diabetes Mellitus (1985) World Health Organization Tech Rep Ser 272, WHO, Geneva
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 J. F. Bergmann Verlag, München
About this paper
Cite this paper
Panzram, G. (1987). Epidemiologie der Arteriosklerose bei Diabetes mellitus. In: Miehlke, K. (eds) Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 93. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85460-6_101
Download citation
DOI: https://doi.org/10.1007/978-3-642-85460-6_101
Publisher Name: J.F. Bergmann-Verlag
Print ISBN: 978-3-8070-0364-1
Online ISBN: 978-3-642-85460-6
eBook Packages: Springer Book Archive